Isoniazid resistance pattern among pulmonary tuberculosis patients in Bangladesh: An exploratory study
Clinical Microbiology and Infection · 2025
DOI: 10.1016/j.cmi.2024.09.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2025. Verfasst von Syed Mohammad Mazidur Rahman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Division, icddr,b, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary, Isoniazid, Antitubercular Agents, Mycobacterium tuberculosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: USAID.
Abstract (Originalsprache)
OBJECTIVES: In high tuberculosis (TB) burden countries such as Bangladesh, research and policy tend to focus on rifampicin (RIF)-resistant TB patients, leaving RIF-sensitive but isoniazid (INH)-resistant (Hr-TB) patients undiagnosed. Our study aims to determine the prevalence of INH resistance among pulmonary TB patients in selected health care facilities in Bangladesh. METHODS: This study was conducted across nine TB Screening and Treatment Centres situated in Bangladesh. Sputum samples from 1084 Xpert-positive pulmonary TB patients were collected between April 2021 and December 2022 and cultured for drug susceptibility testing. Demographic and clinical characteristics of Hr-TB and drug-susceptible TB patients were compared. RESULTS: Among available drug susceptibility testing results of 998 culture-positive isolates, the resistance rate of any INH regardless of RIF susceptibility was 6.4% (64/998, 95% CI: 4.9-8.2). The rate was significantly higher in previously treated (21.1%, 16/76, 95% CI: 12.0-34.2) compared with newly diagnosed TB patients (5.2%, 48/922, 95% CI: 3.8-6.9) (p < 0.001). The rate of Hr-TB was 4.5% (45/998, 95% CI: 3.3-6.0), which was also higher among previously treated patients (6.6%, 5/76, 95% CI: 1.4-13.5) compared with newly diagnosed TB patients (4.3%; 40/922, 95% CI: 3.1-5.9) (p 0.350). Most importantly, the rate of Hr-TB was more than double compared with MDR-TB (4.5%, 45/998, vs. 1.9%, 19/998) found in the current study. DISCUSSION: This study reveals a high prevalence of Hr-TB, surpassing even that of the multi-drug-resistant TB in Bangladesh. This emphasizes the urgent need to adopt WHO-recommended molecular tools at the national level for rapid detection of INH resistance so that patients receive timely and appropriate treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Division, icddr,b, Dhaka, Bangladesh.
- Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, ON, Canada.
- National Tuberculosis Control Programme, Dhaka, Bangladesh.
- USAID STAR Program, National Tuberculosis Control Programme, Dhaka, Bangladesh.
- US Agency for International Development (USAID), Dhaka, Bangladesh.
- Infectious Diseases Division, icddr,b, Dhaka, Bangladesh. Electronic address: sbanu@icddrb.org.
Förderung
- USAID
Zitieren
APA
Rahman, S. M. M., Samina, P., Rahman, T., Adel, A. S. S., Nasrin, R., Uddin, M. K. M., Hasan, M. J., Ahmed, S., Daru, P., Modak, P. K., Salim, M. A. H., Mohsin, S. M. I., & Banu, S. (2025). Isoniazid resistance pattern among pulmonary tuberculosis patients in Bangladesh: An exploratory study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.09.027
Vancouver
Rahman SMM, Samina P, Rahman T, Adel ASS, Nasrin R, Uddin MKM, et al. Isoniazid resistance pattern among pulmonary tuberculosis patients in Bangladesh: An exploratory study. Clinical Microbiology and Infection. 2025. doi:10.1016/j.cmi.2024.09.027
BibTeX
@article{Rahman2025,
author = {Rahman, Syed Mohammad Mazidur and Samina, Pushpita and Rahman, Tanjina and Adel, Ahammad Shafiq Sikder and Nasrin, Rumana and Uddin, Mohammad Khaja Mafij and Hasan, Md Jahid and Ahmed, Shahriar and Daru, Paul and Modak, Pronab Kumar and Salim, Md Abdul Hamid and Mohsin, Sardar Munim Ibna and Banu, Sayera},
title = {Isoniazid resistance pattern among pulmonary tuberculosis patients in Bangladesh: An exploratory study},
journal = {Clinical Microbiology and Infection},
year = {2025},
doi = {10.1016/j.cmi.2024.09.027}
}
EUVIMED